LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy
Status:
Withdrawn
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This is a double-blind, placebo-controlled, study testing whether LDX improves cognitive
function and EF in 20 postmenopausal women who report onset of cognitive difficulties after
oophorectomy (with or without subsequent chemo/adjunctive therapy). Brain imaging is included
at critical time points to obtain objective data regarding effects of LDX as well as
potential predictors of resilience in the face of oophorectomy.